AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 22968185 — intervention group
Group type: EXPERIMENTAL
Intervention: nonsurgical approach to part-solid GGNs (psGGNs) with solid component smaller than 5 mm
Number of subjects: 56
Study 22968185 — intervention group
Group type: EXPERIMENTAL
Intervention: nonsurgical approach to part-solid GGNs (psGGNs) with solid component larger than 5 mm
Number of subjects: 56
Study 22968185 — intervention group
Group type: EXPERIMENTAL
Intervention: nonsurgical approach to GGNs
Number of subjects: 56
Study 19008862 — intervention group
Group type: EXPERIMENTAL
Intervention: In vivo circulating oxLDL measured in hypertensive elderly individuals
Number of subjects: 1130
Study 19008862 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypertensive stages (low to high)
Number of subjects: 1130
Study 17516265 — intervention group
Group type: EXPERIMENTAL
Intervention: Subconjunctival anesthesia
Number of subjects: 30
Study 17516265 — intervention group
Group type: COMPARATOR
Intervention: Retrobulbar anesthesia
Number of subjects: 30
Study 17516265 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 30
Study 16439238 — intervention group
Group type: EXPERIMENTAL
Intervention: Rectus femoris transfer surgery
Number of subjects: 40
Study 12759107 — intervention group
Group type: EXPERIMENTAL
Intervention: Granisetron 2 mg/day
Number of subjects: 128
Study 12759107 — intervention group
Group type: EXPERIMENTAL
Intervention: Granisetron 1 mg/day
Number of subjects: 128
Study 12759107 — intervention group
Group type: COMPARATOR
Intervention: Granisetron 0 mg/day (control)
Number of subjects: 128
Study 12759107 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups treated with a 21‐mg nicotine patch
Number of subjects: 128
Study 10585155 — intervention group
Group type: EXPERIMENTAL
Intervention: Affinity oxygenator with 10 ml of 25% albumin added to the pump prime (Albumin group)
Number of subjects: 56
Study 10585155 — intervention group
Group type: EXPERIMENTAL
Intervention: Trillium-coated Affinity oxygenator (Trillium group)
Number of subjects: 56
Study 10585155 — intervention group
Group type: COMPARATOR
Intervention: Control group (Albumin group)
Number of subjects: 56
Study 8952015 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic antiepileptic drugs (AEDs)
Number of subjects: 6
Study 8952015 — intervention group
Group type: COMPARATOR
Intervention: Control group (no prophylactic AEDs)
Number of subjects: 6
Study 2009894 — intervention group
Group type: EXPERIMENTAL
Intervention: Felodipine 10 mg and Diltiazem 60 mg combination
Number of subjects: 12
Study 2009894 — intervention group
Group type: EXPERIMENTAL
Intervention: Felodipine 10 mg alone
Number of subjects: 12
Study 2009894 — intervention group
Group type: EXPERIMENTAL
Intervention: Diltiazem 60 mg alone
Number of subjects: 12
Study 2009894 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 6355056 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical acyclovir cream
Number of subjects: 0
Study 6355056 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical acyclovir ointment
Number of subjects: 0
Study 6355056 — intervention group
Group type: COMPARATOR
Intervention: Placebo (polyethylene glycol ointment and modified aqueous cream)
Number of subjects: 0
Study 31535371 — intervention group
Group type: EXPERIMENTAL
Intervention: Parenting for Lifelong Health (PLH) program
Number of subjects: 296
Study 31535371 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 296
Study 31405391 — intervention group
Group type: EXPERIMENTAL
Intervention: Online family problem-solving therapy (OFPST)
Number of subjects: 359
Study 31405391 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 359
Study 27828768 — intervention group
Group type: EXPERIMENTAL
Intervention: Natural Curcumin (100 mg/L)
Number of subjects: 50
Study 27828768 — intervention group
Group type: EXPERIMENTAL
Intervention: Photogem (100 mg/L)
Number of subjects: 50
Study 27828768 — intervention group
Group type: EXPERIMENTAL
Intervention: Natural Curcumin (25 mg/L)
Number of subjects: 50
Study 27828768 — intervention group
Group type: EXPERIMENTAL
Intervention: Photogem (25 mg/L)
Number of subjects: 50
Study 27828768 — intervention group
Group type: COMPARATOR
Intervention: Water control
Number of subjects: 50
Study 27828768 — intervention group
Group type: COMPARATOR
Intervention: PS control
Number of subjects: 50
Study 27828768 — intervention group
Group type: COMPARATOR
Intervention: Light control
Number of subjects: 50
Study 25585083 — intervention group
Group type: EXPERIMENTAL
Intervention: Sacral nerve modulation ON
Number of subjects: 31
Study 25585083 — intervention group
Group type: COMPARATOR
Intervention: Sacral nerve modulation OFF
Number of subjects: 31
Study 23539534 — intervention group
Group type: EXPERIMENTAL
Intervention: PH-797804 3 mg
Number of subjects: 230
Study 23539534 — intervention group
Group type: EXPERIMENTAL
Intervention: PH-797804 6 mg
Number of subjects: 230
Study 23539534 — intervention group
Group type: EXPERIMENTAL
Intervention: PH-797804 3 mg and 6 mg
Number of subjects: 230
Study 23539534 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 230
Study 21665112 — intervention group
Group type: EXPERIMENTAL
Intervention: Electric point stimulator type of TENS
Number of subjects: 60
Study 21665112 — intervention group
Group type: COMPARATOR
Intervention: Placebo (detuned electric point stimulator type of TENS)
Number of subjects: 60
Study 19766947 — intervention group
Group type: EXPERIMENTAL
Intervention: PSUNC exposure (treatment)
Number of subjects: 1969
Study 19766947 — intervention group
Group type: COMPARATOR
Intervention: No exposure (control)
Number of subjects: 1969
Study 16412464 — intervention group
Group type: EXPERIMENTAL
Intervention: Mirtazapine
Number of subjects: 48
Study 16412464 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study 12635671 — intervention group
Group type: EXPERIMENTAL
Intervention: dorzolamide 3 times daily for 4 weeks
Number of subjects: 20
Study 12635671 — intervention group
Group type: EXPERIMENTAL
Intervention: latanoprost once daily for 4 weeks
Number of subjects: 20
Study 10848925 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide (800 microg b.d.)
Number of subjects: 25
Study 10848925 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study 9176828 — intervention group
Group type: EXPERIMENTAL
Intervention: Pediasure with approximately 10 g total dietary fiber/l (PSF10)
Number of subjects: 20
Study 9176828 — intervention group
Group type: COMPARATOR
Intervention: Pediasure (PS)
Number of subjects: 20
Study 9176828 — intervention group
Group type: EXPERIMENTAL
Intervention: Pediasure with fiber (PSF10)
Number of subjects: 20
Study 1544291 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg bromfenac
Number of subjects: 280
Study 1544291 — intervention group
Group type: EXPERIMENTAL
Intervention: 25 mg bromfenac
Number of subjects: 280
Study 1544291 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg bromfenac
Number of subjects: 280
Study 1544291 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg bromfenac
Number of subjects: 280
Study 1544291 — intervention group
Group type: EXPERIMENTAL
Intervention: 650 mg aspirin
Number of subjects: 280
Study 1544291 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 mg ibuprofen
Number of subjects: 280
Study 1544291 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 280
Study 3909375 — intervention group
Group type: EXPERIMENTAL
Intervention: Gluten-free diet for 16-36 months (mean, 20 months)
Number of subjects: 41
Study 3909375 — intervention group
Group type: COMPARATOR
Intervention: Non-restricted diet for 17-35 months (mean, 20 months)
Number of subjects: 41
Study 30688501 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual-perceptual group (temporal occlusion training)
Number of subjects: 39
Study 30688501 — intervention group
Group type: EXPERIMENTAL
Intervention: Visuomotor group (temporal occlusion training + motor pattern practice)
Number of subjects: 39
Study 30688501 — intervention group
Group type: COMPARATOR
Intervention: No-training control group
Number of subjects: 39
Study 28440343 — intervention group
Group type: EXPERIMENTAL
Intervention: Sildenafil (high-dose)
Number of subjects: 85
Study 26400818 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine
Number of subjects: 50
Study 25306234 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic adhesiolysis
Number of subjects: 102
Study 25306234 — intervention group
Group type: COMPARATOR
Intervention: Open surgery
Number of subjects: 102
Study 22801672 — intervention group
Group type: EXPERIMENTAL
Intervention: Escitalopram, 10 mg/d (n = 90)
Number of subjects: 181
Study 22801672 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n = 91)
Number of subjects: 181
Study 19862667 — intervention group
Group type: EXPERIMENTAL
Intervention: Colesevelam hydrochloride 3.75 g/day
Number of subjects: 509
Study 17908665 — intervention group
Group type: EXPERIMENTAL
Intervention: Parsonnet score
Number of subjects: 622
Study 17908665 — intervention group
Group type: EXPERIMENTAL
Intervention: Tu score
Number of subjects: 622
Study 17908665 — intervention group
Group type: EXPERIMENTAL
Intervention: Logistic regression
Number of subjects: 622
Study 16204422 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational video about Tourette's Syndrome (TS)
Number of subjects: 170
Study 16204422 — intervention group
Group type: COMPARATOR
Intervention: Video about depression
Number of subjects: 170
Study 16204422 — intervention group
Group type: COMPARATOR
Intervention: No educational video
Number of subjects: 170
Study 11168740 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc citrate toothpaste with 1% triglyceride oil
Number of subjects: 24
Study 11168740 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc citrate toothpaste with 8% triglyceride oil
Number of subjects: 24
Study 11168740 — intervention group
Group type: COMPARATOR
Intervention: Conventional commercial fluoride control toothpaste
Number of subjects: 24
Study 9553537 — intervention group
Group type: COMPARATOR
Intervention: Compression hip screw
Number of subjects: 160
Study 9553537 — intervention group
Group type: EXPERIMENTAL
Intervention: Medoff sliding plate
Number of subjects: 160
Study 9553537 — intervention group
Group type: EXPERIMENTAL
Intervention: Both devices
Number of subjects: 160
Study 7848349 — intervention group
Group type: EXPERIMENTAL
Intervention: Deponit 5 (test patch)
Number of subjects: 37
Study 7848349 — intervention group
Group type: COMPARATOR
Intervention: Reference patch
Number of subjects: 37
Study 3287884 — intervention group
Group type: EXPERIMENTAL
Intervention: Hexabrix
Number of subjects: 82
Study 3287884 — intervention group
Group type: COMPARATOR
Intervention: Renografin
Number of subjects: 82
Study 29643045 — intervention group
Group type: COMPARATOR
Intervention: 0.9-ms 1064-nm Nd:YAG laser alone
Number of subjects: 37
Study 29643045 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.9-ms 1064-nm Nd:YAG laser combined with itraconazole
Number of subjects: 37
Study 28061794 — intervention group
Group type: EXPERIMENTAL
Intervention: DQIP intervention (data-driven quality improvement in primary care)
Number of subjects: 0
Study 25141907 — intervention group
Group type: EXPERIMENTAL
Intervention: α1‐adrenoceptor antagonists (tamsulosin)
Number of subjects: 155
Study 25141907 — intervention group
Group type: EXPERIMENTAL
Intervention: uroflowmetry biofeedback combined with α1‐adrenoceptor antagonists
Number of subjects: 155
Study 25141907 — intervention group
Group type: COMPARATOR
Intervention: All groups (including control)
Number of subjects: 155
Study 23268373 — intervention group
Group type: EXPERIMENTAL
Intervention: ACL reconstruction patients (operated limb)
Number of subjects: 45
Study 23268373 — intervention group
Group type: EXPERIMENTAL
Intervention: ACL reconstruction patients (non-operated limb)
Number of subjects: 45
Study 23268373 — intervention group
Group type: COMPARATOR
Intervention: Secondary task (both groups)
Number of subjects: 45
Study 21216208 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture stimulation at CV17
Number of subjects: 14
Study 21216208 — intervention group
Group type: COMPARATOR
Intervention: Acupuncture stimulation at CV16
Number of subjects: 14
Study 18452256 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 microg/kg remifentanil (Group II)
Number of subjects: 90
Study 18452256 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 microg/kg remifentanil (Group III)
Number of subjects: 90
Study 18452256 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (Group I)
Number of subjects: 90
Study 16921684 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbon dioxide insufflation at 6 L/min through a Jackson Pratt drain into the pericardium during cardiopulmonary bypass
Number of subjects: 43
Study 16921684 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 43
Study 12943177 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA)
Number of subjects: 35
Study 12943177 — intervention group
Group type: EXPERIMENTAL
Intervention: Moxibustion (Mox)
Number of subjects: 35
Study 12943177 — intervention group
Group type: COMPARATOR
Intervention: Control (routine acupuncture therapy and ROM exercise)
Number of subjects: 35
Study 10379478 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic polypectomies (425 total, mean of 23.6 per patient)
Number of subjects: 37
Study 10379478 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of microadenomas
Number of subjects: 37
Study 10379478 — intervention group
Group type: EXPERIMENTAL
Intervention: Helicobacter pylori search
Number of subjects: 37
Study 8829883 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobionate-based solutions
Number of subjects: 0
Study 8829883 — intervention group
Group type: COMPARATOR
Intervention: Hypertonic citrate solutions
Number of subjects: 0
Study 8829883 — intervention group
Group type: COMPARATOR
Intervention: Extracellular solutions
Number of subjects: 0
Study 2072494 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 mg.kg‐1 pethidine (group 1)
Number of subjects: 22
Study 2072494 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.7 mg.kg‐1 pethidine (group 2)
Number of subjects: 22
Study 2072494 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (0.5 mg.kg‐1 and 0.7 mg.kg‐1 pethidine)
Number of subjects: 22
Study 6418905 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose branched-chain amino acid (BcAA) hyperalimentation (45% BcAA)
Number of subjects: 0
Study 6418905 — intervention group
Group type: COMPARATOR
Intervention: Standard amino acid solution (24.2% BcAA)
Number of subjects: 0
Study 30935324 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal manipulative therapy (SMT)
Number of subjects: 29
Study 30935324 — intervention group
Group type: COMPARATOR
Intervention: Sham spinal manipulative therapy (sham SMT)
Number of subjects: 29
Study 30102338 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-genome sequencing of EBV-positive NPC samples
Number of subjects: 12
Study 30102338 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional analyses of FBXO11 gene
Number of subjects: 12
Study 30102338 — intervention group
Group type: EXPERIMENTAL
Intervention: Assembly of full-length EBV genomes
Number of subjects: 12
Study 27023407 — intervention group
Group type: EXPERIMENTAL
Intervention: Miniscrews
Number of subjects: 80
Study 25041620 — intervention group
Group type: EXPERIMENTAL
Intervention: Intralesional recombinant human epidermal growth factor (rhEGF) 75 μg, thrice-per-week for 8 weeks
Number of subjects: 31
Study 25041620 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study 22211683 — intervention group
Group type: EXPERIMENTAL
Intervention: High Fat Meal with Fruit Juice Drink (HFM-FJD)
Number of subjects: 14
Study 22211683 — intervention group
Group type: COMPARATOR
Intervention: High Fat Meal with Placebo (HFM-P)
Number of subjects: 14
Study 20142693 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous passive motion (CPM) thrice daily and physical therapy (PT) twice daily during hospitalization.
Number of subjects: 0
Study 20142693 — intervention group
Group type: COMPARATOR
Intervention: Physical therapy (PT) twice daily during hospitalization (Control group).
Number of subjects: 0
Study 18613962 — intervention group
Group type: EXPERIMENTAL
Intervention: Artemisinin combination therapies (ACT)
Number of subjects: 3174
Study 15792396 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketoconazole (400 mg once daily) alone
Number of subjects: 32
Study 15792396 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketoconazole (400 mg once daily) and telithromycin (800 mg once daily) given concomitantly
Number of subjects: 32
Study 15792396 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketoconazole (400 mg once daily) and clarithromycin (500 mg twice daily) given concomitantly
Number of subjects: 32
Study 15792396 — intervention group
Group type: EXPERIMENTAL
Intervention: Telithromycin plus ketoconazole
Number of subjects: 32
Study 14622692 — intervention group
Group type: EXPERIMENTAL
Intervention: Opioids long-term
Number of subjects: 200
Study 14622692 — intervention group
Group type: COMPARATOR
Intervention: Nonsteroidal anti-inflammatory drugs long-term
Number of subjects: 200
Study 10499947 — intervention group
Group type: EXPERIMENTAL
Intervention: Prochlorperazine (PCZ) 10 mg intravenous
Number of subjects: 140
Study 10499947 — intervention group
Group type: COMPARATOR
Intervention: Nonakathisic intravenous therapy (saline solution or antibiotics)
Number of subjects: 140
Study 8738691 — intervention group
Group type: EXPERIMENTAL
Intervention: pH-stat (n = 23)
Number of subjects: 45
Study 8738691 — intervention group
Group type: COMPARATOR
Intervention: alpha-stat (n = 22)
Number of subjects: 45
Study 1843106 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemoradiotherapy
Number of subjects: 0
Study 1843106 — intervention group
Group type: EXPERIMENTAL
Intervention: Concurrent chemoradiotherapy
Number of subjects: 0
Study 7049587 — intervention group
Group type: EXPERIMENTAL
Intervention: Amiloride/hydrochlorothiazide combination (2 tablets per day of 5 mg amiloride plus 50 mg hydrochlorothiazide)
Number of subjects: 24
Study 7049587 — intervention group
Group type: COMPARATOR
Intervention: Hydrochlorothiazide alone (50 mg hydrochlorothiazide)
Number of subjects: 24
Study 6140973 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxypertine
Number of subjects: 33
Study 6140973 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study 29464385 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine (0.5 mg/kg administered via i.v. 20 minutes before surgery completion)
Number of subjects: 140
Study 29464385 — intervention group
Group type: COMPARATOR
Intervention: Saline (1 ml administered via i.v. 20 minutes before surgery completion)
Number of subjects: 140
Study 27305293 — intervention group
Group type: EXPERIMENTAL
Intervention: 8-week anger management programme followed by a 4-week psychosocial impact intervention
Number of subjects: 26
Study 27305293 — intervention group
Group type: COMPARATOR
Intervention: Psychosocial adjustment programme
Number of subjects: 26
Study 24673708 — intervention group
Group type: EXPERIMENTAL
Intervention: Zoledronic acid (ZOL; 4 mg intravenously every 21-28 days)
Number of subjects: 1960
Study 24673708 — intervention group
Group type: COMPARATOR
Intervention: Clodronate (CLO; 1600 mg/d orally)
Number of subjects: 1960
Study 24673708 — intervention group
Group type: EXPERIMENTAL
Intervention: Zoledronic acid (ZOL)
Number of subjects: 1960
Study 24673708 — intervention group
Group type: COMPARATOR
Intervention: Clodronate (CLO)
Number of subjects: 1960
Study 22798380 — intervention group
Group type: EXPERIMENTAL
Intervention: Performance-based measures (walking speed)
Number of subjects: 148
Study 22798380 — intervention group
Group type: EXPERIMENTAL
Intervention: Performance-based measures (Physical Performance and Mobility Examination)
Number of subjects: 148
Study 22798380 — intervention group
Group type: EXPERIMENTAL
Intervention: Performance-based measures (chair-rise test)
Number of subjects: 148
Study 22798380 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-reported mobility
Number of subjects: 148
Study 22798380 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-reported strength
Number of subjects: 148
Study 22798380 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-reported balance
Number of subjects: 148
Study 22798380 — intervention group
Group type: EXPERIMENTAL
Intervention: Measures of body sway
Number of subjects: 148
Study 20835640 — intervention group
Group type: EXPERIMENTAL
Intervention: Open suction system (OSS)
Number of subjects: 39
Study 20835640 — intervention group
Group type: COMPARATOR
Intervention: Closed suction system (CSS)
Number of subjects: 39
Study 20835640 — intervention group
Group type: EXPERIMENTAL
Intervention: Both OSS and CSS
Number of subjects: 39
Study 18931221 — intervention group
Group type: EXPERIMENTAL
Intervention: Forced-air warming (Bair Hugger warming cover #300, blower #750)
Number of subjects: 8
Study 18931221 — intervention group
Group type: EXPERIMENTAL
Intervention: Polymer fiber resistive warming (HotDog whole body blanket)
Number of subjects: 8
Study 18931221 — intervention group
Group type: COMPARATOR
Intervention: Comparison of both systems
Number of subjects: 8
Study 15904654 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine administration
Number of subjects: 0
Study 15904654 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 14657744 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified group with open door type of cervical en bloc laminoplasty, bone grafts placed at three levels, no grafting in hinged side, neck collar worn for 1 month, early exercise of posterior neck muscle advised.
Number of subjects: 0
Study 14657744 — intervention group
Group type: COMPARATOR
Intervention: Control group with original operation and postoperative therapy, bone grafts from dissected spinous processes, grafts placed from three to five levels, orthosis applied for up to 1 month, neck collar recommended for 1 additional month.
Number of subjects: 0
Study 14657744 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified group
Number of subjects: 0
Study 14657744 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 10584416 — intervention group
Group type: EXPERIMENTAL
Intervention: Local addition of ketoprofen (1:400) with 4 ml of 1% lidocaine
Number of subjects: 1000
Study 10584416 — intervention group
Group type: COMPARATOR
Intervention: Control group (without ketoprofen) with 4 ml of 1% lidocaine
Number of subjects: 1000
Study 8729628 — intervention group
Group type: EXPERIMENTAL
Intervention: Albendazole treatment (N = 49)
Number of subjects: 97
Study 8729628 — intervention group
Group type: COMPARATOR
Intervention: Placebo (N = 48)
Number of subjects: 97
Study 8729628 — intervention group
Group type: EXPERIMENTAL
Intervention: Infected group (N = 49)
Number of subjects: 97